{"cluster": 50, "subcluster": 48, "abstract_summ": "Currently, over 150 countries have reported COVID-19 cases, and the situation has progressed to a pandemic associated with substantial morbidity and mortality.1.Coronavirus disease 2019 (COVID\u201019), caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102), has spread rapidly around the world.Since the coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) first emerged in Wuhan, China in December 2019, the outbreak of COVID-19 epidemic has become an increasingly serious global health concern.Some reports further indicate that a subset of COVID\u201019 patients may continue to have positive SARS\u2010CoV\u20102 anal/rectal swab and stool test after negative conversion of nasopharyngeal test.An outbreak of coronavirus disease 2019 (COVID\u201019) pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102), started in Wuhan City, Hubei Province, China.Currently, the identification of this disease is mainly conducted by using nasopharyngeal swabs([1]), but the presence of SARS\u2010CoV\u20102 RNA in feces of COVID\u201019 patients indicates the possibility of transmission via fecal\u2010oral route([2\u20104]).", "title_summ": "SARS\u2010CoV\u20102 and the Hidden Carriers \u2013 Sewage, Feline, and Blood TransfusionRecurrence of positive SARS\u2010CoV\u20102 in patients recovered from COVID\u201019Prolonged SARS\u2010Cov\u20102 RNA Detection in Anal/Rectal Swabs and Stool Specimens in COVID\u201019 Patients After Negative Conversion in Nasopharyngeal RT\u2010PCR TestSARS\u2010CoV, Mers\u2010CoV and Covid\u201019:what differences from a dermatological viewpoint?Distinct characteristics of COVID\u201019 patients with initial rRT\u2010PCR\u2010positive and rRT\u2010PCR\u2010negative results for SARS\u2010CoV\u20102Asymptomatic SARS\u2010CoV\u20102 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 daysDetection of SARS\u2010CoV\u20102 by RT\u2010PCR in anal from patients who have recovered from coronavirus disease 2019", "title_abstract_phrases": "Currently, over 150 countries have reported COVID-19 cases, and the situation has progressed to a pandemic associated with substantial morbidity and mortality.1.Asymptomatic SARS\u2010CoV\u20102 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 daysCoronavirus disease 2019 (COVID\u201019), caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102), has spread rapidly around the world.Some reports further indicate that a subset of COVID\u201019 patients may continue to have positive SARS\u2010CoV\u20102 anal/rectal swab and stool test after negative conversion of nasopharyngeal test.Distinct characteristics of COVID\u201019 patients with initial rRT\u2010PCR\u2010positive and rRT\u2010PCR\u2010negative results for SARS\u2010CoV\u20102Since the coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) first emerged in Wuhan, China in December 2019, the outbreak of COVID-19 epidemic has become an increasingly serious global health concern.Detection of SARS\u2010CoV\u20102 by RT\u2010PCR in anal from patients who have recovered from coronavirus disease 2019An outbreak of coronavirus disease 2019 (COVID\u201019) pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102), started in Wuhan City, Hubei Province, China.Recurrence of positive SARS\u2010CoV\u20102 in patients recovered from COVID\u201019Recurrence of positive SARS CoV\u20102 PCR has been described in patients discharged from hospital after 2 consecutive negative PCR."}